SCHEMBL4729264

SCHEMBL4729264

CCOC(=O)C1CCCc2c1[nH]c1ccc(Cl)c(Cl)c21

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.68
KMT2A Q03164 3/20 0.68
MAPT P10636 2/20 0.68
LMNA P02545 2/20 0.68
GAA P10253 1/20 0.61
HTT P42858 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
ALDH1A1 P00352 1/20 0.52
KDM4E B2RXH2 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALOX15 P16050 2/20 0.47
TP53 P04637 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SIRT1 Q96EB6 13/20 0.44
SIRT2 Q8IXJ6 4/20 0.43
SIRT3 Q9NTG7 2/20 0.43
RECQL P46063 1/20 0.43
TSHR P16473 1/20 0.40
AR P10275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4780145 0.90 MEN1 (0.64) MEN1KMT2AMAPTLMNAGAA
SCHEMBL31328307 0.90 MEN1 (0.64) MEN1KMT2AMAPTLMNAGAA
SCHEMBL8220387 0.90 MEN1 (0.67) MEN1KMT2AMAPTLMNAGAA
SCHEMBL16266056 0.83 MEN1 (0.67) MEN1KMT2AMAPTLMNAGAA
SCHEMBL4726198 0.83 SIRT1 (0.55) MEN1KMT2AMAPTLMNAGAA
SCHEMBL4779722 0.82 SIRT1 (0.62) MEN1KMT2AMAPTLMNAALOX15
SCHEMBL4725046 0.81 MEN1 (1.00) MEN1KMT2AMAPTLMNAGAA
SCHEMBL31612407 0.81 MEN1 (1.00) MEN1KMT2AMAPTLMNAGAA
SCHEMBL34464423 0.81 MEN1 (0.60) MEN1KMT2AMAPTLMNAGAA
SCHEMBL31328320 0.81 MEN1 (0.60) MEN1KMT2AMAPTLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008019825-A1 USE OF TRICYCLIC INDOLE DERIVATIVES FOR THE TREATMENT OF MUSCULAR DISEASES SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) 2008-02-21 WO disclosed
WO-2008019825-A1 USE OF TRICYCLIC INDOLE DERIVATIVES FOR THE TREATMENT OF MUSCULAR DISEASES SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) 2008-02-21 WO disclosed